🇺🇸 Anastrozole (Arimidex) in United States

30 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Breast Cancer Metastatic — 3 reports (10%)
  2. Dehydration — 3 reports (10%)
  3. Diarrhoea — 3 reports (10%)
  4. Dizziness — 3 reports (10%)
  5. Malignant Ascites — 3 reports (10%)
  6. Muscle Spasms — 3 reports (10%)
  7. Nausea — 3 reports (10%)
  8. Pain — 3 reports (10%)
  9. Pruritus — 3 reports (10%)
  10. Urticaria — 3 reports (10%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Anastrozole (Arimidex) approved in United States?

Anastrozole (Arimidex) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Anastrozole (Arimidex) in United States?

University of British Columbia is the originator. The local marketing authorisation holder may differ — check the official source linked above.